---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-002865"
form_type: "8-K"
ticker: "RLMD"
cik: "0001553643"
company_name: "RELMADA THERAPEUTICS, INC."
filed_at: "2023-01-17T23:59:59+00:00"
generated_at: "2026-06-20T14:41:53.576826+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Relmada Therapeutics appoints Fabiana Fedeli to board of directors

## Summary
- Board expanded from 5 to 6 members; Fedeli appointed Class I director effective Jan 12, 2023.
- Annual cash compensation: $66k as director, $9.9k audit committee, $7.7k compensation committee.
- Granted option to buy 200,000 shares at $4.22, vesting over 4 years, subject to shareholder approval.
- Fedeli is Chief Investment Officer at M&G Investments and was named in Financial News' 100 Most Influential Women in Finance.

## SEC filing metadata
- accession: 0001213900-23-002865
- form_type: 8-K
- ticker: RLMD
- cik: 0001553643
- company_name: RELMADA THERAPEUTICS, INC.
- filed_at: 2023-01-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553643/000121390023002865/0001213900-23-002865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553643/000121390023002865/ea171670-8k_relmada.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-002865
- JSON: https://secwatch.observer/filing/0001213900-23-002865.json
- Plain text: https://secwatch.observer/filing/0001213900-23-002865.txt

## Key facts
- Executive change
  Fabiana Fedeli was appointed as Director at RELMADA THERAPEUTICS, INC..
  - Action: appointed
  - Role: Director
  source text: increased the number of directors constituting the whole board from five to six and appointed Fabiana Fedeli as a Class I director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1553643/000121390023002865/0001213900-23-002865-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.